The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.

Van Den Broek, A K; Visser, C E; Veenstra, J; Van Den Berg, B T J; Prins, J M; Van Hest, R M

Van Den Broek, A K; Visser, C E; Veenstra, J; Van Den Berg, B T J; Prins, J M; Van Hest, R M.

Afiliación

Van Den Broek AK; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Visser CE; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Veenstra J; Department of Internal Medicine, OLVG, location West, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands.
Van Den Berg BTJ; Department of Pulmonology, OLVG, location West, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands.
Prins JM; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Van Hest RM; Department of Hospital Pharmacy, Division of Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

J Antimicrob Chemother ; 78(2): 389-396, 2023 02 01.

Article en En | MEDLINE | ID: mdl-36433818

Asunto(s)

Antibacterianos; Ciprofloxacina; Humanos; Amoxicilina; Fiebre/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ciprofloxacina / Antibacterianos Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google